TORONTO — (Marketwire) — 11/09/12 — A Report to Shareholders released today by Nano Labs Corp. (OTCQB: CTLE) — a nanotechnology development company — brought encouraging news from the company’s recently appointed Chief Research and Innovation Officer. Dr. Victor Castano told shareholders, “on behalf of the Nano Labs Board of Directors, I am pleased to report that our new road map and business plan for success through 2013 aim to make Nano Labs the company to watch as a rising American star in emerging technologies.”
Dr. Castano said, “We have positioned our young company to fire on all cylinders. Our people, products and facilities have come together in a North American alliance that we believe uniquely positions us for aggressive growth and success across multiple industry sectors. Through our R&D facilities in Mexico, our headquarters in Detroit, and our marketing resources in Toronto, we are already working towards patent finalization, testing, certification and commercialization of five remarkable nanotech applications relating to energy, medicine, and industrial and consumer goods, respectively. I look forward to discussing these in more detail in the coming days and weeks as we file our new business plan, launch our new website, and finalize details involving patents and intellectual property rights.”
Dr. Castano remarked about two intriguing nanotech solutions. First, the company is working to finalize the patent application for a remarkable surface coating boasting fire-resistant characteristics at up to 1,500 degrees Celsius, which may be used in numerous types of industrial and consumer goods. The other solution is a process to turn organic solutions into applications for various industrial and commercial uses. In describing this process in the Shareholders’ Report, Dr. Castano added a touch of humor. “We have also developed a nanotech process whereby we turn organic solutions — such as acetone and ethanol (including tequila) — into diamond film for industrial and possibly consumer use. But of course, we have been, and will continue to be, very sober in the approach we take when turning tequila into diamonds.”
Altogether, the initiatives involve just a few of the innovations Dr. Castano brings with him as an internationally celebrated scientist working for some 30 years in the field of nanotechnology. Dr. Castano reported that as he works with a team of scientists, technicians and executive-level business and marketing professionals, Nano Labs is exploring other fronts to take full advantage of its diversified base of more than 500 peer-reviewed papers, products, and prototypes relating to energy & fuel, health & medicine, food & agriculture, and building & industrial materials.
“Nanotechnology no longer promises to change the world, the change is right now in progress. And I am delighted that we as shareholders of Nano Labs stock are all aboard a ship headed for what we believe could be hugely profitable and beneficial horizons. We are working to create products and materials that come with the satisfying investment benefit of making our industries stronger, our economies healthier, and our environment safer. Indeed, it’s amazing what science and industry are now capable of achieving through the modification and manipulation of matter at molecular and atomic scales,” Dr. Castano said.
“In addition, we believe that nanotechnology presents a potentially attractive opportunity for Nano Labs’ investors. Let’s just keep in mind that right now, we believe the world is looking at a sea of change in innovative nanotechnology, with research pointing to the prospect of $2.6 trillion in global revenues for the sector — representing 15 per cent of all projected global manufacturing — by 2014. These revenues contrast with $13 billion in 2004. That, in our estimation, is phenomenal growth,” he said.
“We here at Nano Labs believe that we are at the vanguard. In my estimation, we are riding the crest of a wave of such a significant impact that it effectively amounts to a new American industrial revolution. We hope that you join us on our journey,” Dr. Castano told shareholders.
“I look forward to keeping the Company’s shareholders up to date about our aggressive business plan to create strategic and commercial partnerships and joint ventures. In our view, prospects for long-term national and international relationships with significant global brand licensing and distribution partners are looking very good indeed. During my tenure as Chief Research and Innovation Officer, I will be lecturing at various of the leading R&D and education institutions in the world to discuss the promise of nanotechnology. I honestly believe that it is all forward from here,” Dr. Castano said.
About Nano Labs Corp.
Nano Labs Corp. (CTLE) (the “Company,” “we” or “us”), a Colorado corporation, was founded in October 2012, but it is able to rely upon resources that include over 30 years of research and development in nanotechnology and more than 500 peer-reviewed and published research papers and patents. The Company’s research and development team of scientists, designers, and engineers are focused on creating a portfolio of products of next-generation products in the consumer products, energy, materials science, pharmaceutical and healthcare industries. Through the use, and integration of proprietary nano compounds, our goal is to evolve everyday, existing products, into new, revolutionary products, in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit http://www.NanoLabs.us.
Forward looking statements
This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements. Risk factors listed from time to time in its news releases and its filings with the OTC Bulletin Board may materially and adversely affect the Company’s actual performance and future results.